De-Pei Wu (Depei Wu)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 66

Top Topics

Acute Myeloid Leukemia

Stem Cell Transplantation

Top Venues

Blood cancer journal

Bone marrow transplantation

Signal transduction and targeted therapy

Microbiology spectrum

This page only lists publications with an associated author ORCID identifier.

Publications

Liangliang Wu, Limin Liu, Xin Zhao, Ming Zhou, Andie Fu, Yuping Zhang, Wenrui Yang, Xiaowei Chen, Wenjian Mo, Caixia Wang, Yumiao Li, Shilin Xu, Shiyi Pan, Ruiqing Zhou, Fankai Meng, Fengkui Zhang, De-Pei Wu, Shunqing Wang
Unrelated donor hematopoietic stem cell transplantation compared to immunosuppressive therapy plus eltrombopag as first-line treatment for adults with severe aplastic anemia. Blood cancer journal 14 (1) (2024)
Jinjin Zhu, Mimi Xu, Yi-Shan Ye, Yuhua Ru, Yiyang Ding, Xiaoli Li, Huanle Gong, Biqi Zhou, Yi Fan, Yuqing Tu, Yang Xu, He Huang, Jia Chen, De-Pei Wu
Haploidentical-cord blood stem cell transplantation versus haploidentical stem cell transplantation for non-CR acute leukemia patients: a multicenter study. Bone marrow transplantation 59 (9) (2024)
Zhibo Zhang, Jia Yin, Guoli Lian, Xiebing Bao, Meng Hu, Zhenfang Liu, Yuan Yu, Ruihua Mi, Yabei Zuo, Pengcheng Shi, Weiyan Zheng, Qian Jiang, Hongying Chao, Peifang Xiao, Weijuan Yu, Yanqiu Han, Yu Wu, Yan Zeng, De-Pei Wu, Xiaofei Yang, Su-Ning Chen
A multi-center retrospective comparison between systemic mastocytosis with t(8;21) AML and KIT mutant t(8;21) AML. Blood advances (2024)
Biqi Zhou, Jia Chen, Tianhui Liu, Yishan Ye, Yanming Zhang, Yiyang Ding, Hong Liu, MingQing Zhu, Xiao Ma, Xiaoli Li, Longfei Zhao, Zhihong Lin, He Huang, Yang Xu, De-Pei Wu
Haploidentical hematopoietic cell transplantation with or without an unrelated cord blood unit for adult acute myeloid leukemia: a multicenter, randomized, open-label, phase 3 trial. Signal transduction and targeted therapy 9 (1) (2024)
Yue Song, Fei Zhou, Feng Du, Ziyan Wang, Liyun Bai, Yifang Yao, Limin Liu, Xiao Ma, Suning Chen, De-Pei Wu, Xuefeng He
Combined emapalumab and ruxolitinib in patients with haemophagocytic Lymphohistiocytosis. Blood cancer journal 14 (1) (2024)
Liangliang Wu, Limin Liu, Xin Zhao, Ming Zhou, Andie Fu, Yuping Zhang, Wenrui Yang, Xiaowei Chen, Wenjian Mo, Caixia Wang, Yumiao Li, Shilin Xu, Shiyi Pan, Ruiqing Zhou, Fankai Meng, Fengkui Zhang, De-Pei Wu, Shunqing Wang
Unrelated donor hematopoietic stem cell transplantation compared to immunosuppressive therapy plus eltrombopag as first-line treatment for adults with severe aplastic anemia. Blood cancer journal 14 (1) (2024)
Qian Wu, Xiaofei Yang, Jingren Zhang, Mengxing Xue, Xueqing Dou, Zheng Ge, Yifei Chen, Weiying Gu, Weimin Dong, Hongying Cao, Naike Jiang, Xuemei Sun, Zefa Liu, Jinning Shi, Hui Chen, Cixian Zhang, Fengling Min, Hongli Sun, Xiaoli Qian, Hongjian Yuan, Yuan Feng, De-Pei Wu, Suning Chen
Improved prevention and treatment strategies for differentiation syndrome contribute to reducing early mortality in patients with acute promyelocytic leukemia. Blood cancer journal 14 (1) (2024)
Biqi Zhou, Jia Chen, Tianhui Liu, Yishan Ye, Yanming Zhang, Yiyang Ding, Hong Liu, MingQing Zhu, Xiao Ma, Xiaoli Li, Longfei Zhao, Zhihong Lin, He Huang, Yang Xu, De-Pei Wu
Haploidentical hematopoietic cell transplantation with or without an unrelated cord blood unit for adult acute myeloid leukemia: a multicenter, randomized, open-label, phase 3 trial. Signal transduction and targeted therapy 9 (1) (2024)
Liangliang Wu, Limin Liu, Xin Zhao, Ming Zhou, Andie Fu, Yuping Zhang, Wenrui Yang, Xiaowei Chen, Wenjian Mo, Caixia Wang, Yumiao Li, Shilin Xu, Shiyi Pan, Ruiqing Zhou, Fankai Meng, Fengkui Zhang, De-Pei Wu, Shunqing Wang
Unrelated donor hematopoietic stem cell transplantation compared to immunosuppressive therapy plus eltrombopag as first-line treatment for adults with severe aplastic anemia. Blood cancer journal 14 (1) (2024)
Qian Wu, Xiaofei Yang, Jingren Zhang, Mengxing Xue, Xueqing Dou, Zheng Ge, Yifei Chen, Weiying Gu, Weimin Dong, Hongying Cao, Naike Jiang, Xuemei Sun, Zefa Liu, Jinning Shi, Hui Chen, Cixian Zhang, Fengling Min, Hongli Sun, Xiaoli Qian, Hongjian Yuan, Yuan Feng, De-Pei Wu, Suning Chen
Improved prevention and treatment strategies for differentiation syndrome contribute to reducing early mortality in patients with acute promyelocytic leukemia. Blood cancer journal 14 (1) (2024)
Jinjin Zhu, Mimi Xu, Yi-Shan Ye, Yuhua Ru, Yiyang Ding, Xiaoli Li, Huanle Gong, Biqi Zhou, Yi Fan, Yuqing Tu, Yang Xu, He Huang, Jia Chen, De-Pei Wu
Haploidentical-cord blood stem cell transplantation versus haploidentical stem cell transplantation for non-CR acute leukemia patients: a multicenter study. Bone marrow transplantation (2024)
Qian Wu, Xiaofei Yang, Jingren Zhang, Mengxing Xue, Xueqing Dou, Zheng Ge, Yifei Chen, Weiying Gu, Weimin Dong, Hongying Cao, Naike Jiang, Xuemei Sun, Zefa Liu, Jinning Shi, Hui Chen, Cixian Zhang, Fengling Min, Hongli Sun, Xiaoli Qian, Hongjian Yuan, Yuan Feng, De-Pei Wu, Suning Chen
Improved prevention and treatment strategies for differentiation syndrome contribute to reducing early mortality in patients with acute promyelocytic leukemia. Blood cancer journal 14 (1) (2024)
Yujie Liu, Yuqing Tu, Jinyan Xiao, Yifan Shen, Biqi Zhou, Qiannan Yang, Lei Yu, Lijuan Qi, Jia Chen, Tianhui Liu, De-Pei Wu, Yang Xu
Clinical outcomes of patients with lymphoid blastic phase of chronic myeloid leukemia treated with CAR T-cell therapy. Blood cancer journal 14 (1) (2024)
Huangdu Hu, Yinping Wang, Jian Sun, Yuting Wang, Junxin Zhou, Qiucheng Shi, Xinhong Han, Yan Jiang, De-Pei Wu, Xiaojun Huang, Yunsong Yu
Risk factors and molecular epidemiology of intestinal colonization by carbapenem-resistant Gram-negative bacteria in patients with hematological diseases: a multicenter case‒control study. Microbiology spectrum 12 (7) (2024)
Yujie Liu, Yuqing Tu, Jinyan Xiao, Yifan Shen, Biqi Zhou, Qiannan Yang, Lei Yu, Lijuan Qi, Jia Chen, Tianhui Liu, De-Pei Wu, Yang Xu
Clinical outcomes of patients with lymphoid blastic phase of chronic myeloid leukemia treated with CAR T-cell therapy. Blood cancer journal 14 (1) (2024)
Biqi Zhou, Jia Chen, Tianhui Liu, Yishan Ye, Yanming Zhang, Yiyang Ding, Hong Liu, MingQing Zhu, Xiao Ma, Xiaoli Li, Longfei Zhao, Zhihong Lin, He Huang, Yang Xu, De-Pei Wu
Haploidentical hematopoietic cell transplantation with or without an unrelated cord blood unit for adult acute myeloid leukemia: a multicenter, randomized, open-label, phase 3 trial. Signal transduction and targeted therapy 9 (1) (2024)
Yifan Shen, Minyuan Liu, Danya Shen, Mengqian Chu, Xuekai Li, Xiang Zhang, Yi Fan, Jia Chen, De-Pei Wu, Shaoyan Hu, Yang Xu
Busulfan plus cyclophosphamide vs. total body irradiation plus cyclophosphamide for allogeneic hematopoietic stem cell transplantation in patients with acute T lymphoblastic leukemia: a large-scale propensity score matching-based study. Bone marrow transplantation (2024)
Zhiyu Zhang, Man Qiao, Xiebing Bao, Jing Lu, Jingren Zhang, Xueqing Dou, Xuefeng He, Xiao-Jin Wu, Chengcheng Fu, Xiao-Wen Tang, Miao Miao, Yue Han, Sheng-Li Xue, Huiying Qiu, Caixia Li, Ying Wang, Zhengming Jin, De-Pei Wu, Su-Ning Chen
Influence of the Omicron outbreak on allo-HSCT recipients in China: a single-center short-term observational cohort study. Bone marrow transplantation 59 (3) (2024)
Biqi Zhou, Jia Chen, Tianhui Liu, Yishan Ye, Yanming Zhang, Yiyang Ding, Hong Liu, MingQing Zhu, Xiao Ma, Xiaoli Li, Longfei Zhao, Zhihong Lin, He Huang, Yang Xu, De-Pei Wu
Haploidentical hematopoietic cell transplantation with or without an unrelated cord blood unit for adult acute myeloid leukemia: a multicenter, randomized, open-label, phase 3 trial. Signal transduction and targeted therapy 9 (1) (2024)
Yi-Shan Ye, Myriam Labopin, Jia Chen, De-Pei Wu, Tobias Gedde-Dahl, Didier Blaise, Gerard Sociè, Edouard Forcade, Urpu Salmenniemi, Sébastien Maury, Jurjen Versluis, Ali Bazarbachi, Arnon Nagler, Eolia Brissot, Lin Li, Yi Luo, Jimin Shi, Fabio Ciceri, He Huang, Florent Malard, Norbert-Claude Gorin
Lower relapse incidence with HAPLO versus MSD or MUD HCTs for AML patients with KMT2A rearrangement: a study from the Global Committee and the ALWP of the EBMT. Blood cancer journal 14 (1) (2024)
Yi-Shan Ye, Myriam Labopin, Jia Chen, De-Pei Wu, Tobias Gedde-Dahl, Didier Blaise, Gerard Sociè, Edouard Forcade, Urpu Salmenniemi, Sébastien Maury, Jurjen Versluis, Ali Bazarbachi, Arnon Nagler, Eolia Brissot, Lin Li, Yi Luo, Jimin Shi, Fabio Ciceri, He Huang, Florent Malard, Norbert-Claude Gorin
Lower relapse incidence with HAPLO versus MSD or MUD HCTs for AML patients with KMT2A rearrangement: a study from the Global Committee and the ALWP of the EBMT. Blood cancer journal 14 (1) (2024)
Yi-Shan Ye, Myriam Labopin, Jia Chen, De-Pei Wu, Tobias Gedde-Dahl, Didier Blaise, Gerard Sociè, Edouard Forcade, Urpu Salmenniemi, Sébastien Maury, Jurjen Versluis, Ali Bazarbachi, Arnon Nagler, Eolia Brissot, Lin Li, Yi Luo, Jimin Shi, Fabio Ciceri, He Huang, Florent Malard, Norbert-Claude Gorin
Lower relapse incidence with HAPLO versus MSD or MUD HCTs for AML patients with KMT2A rearrangement: a study from the Global Committee and the ALWP of the EBMT. Blood cancer journal 14 (1) (2024)
Zhiyu Zhang, Man Qiao, Xiebing Bao, Jing Lu, Jingren Zhang, Xueqing Dou, Xuefeng He, Xiao-Jin Wu, Chengcheng Fu, Xiao-Wen Tang, Miao Miao, Yue Han, Sheng-Li Xue, Huiying Qiu, Caixia Li, Ying Wang, Zhengming Jin, De-Pei Wu, Su-Ning Chen
Influence of the Omicron outbreak on allo-HSCT recipients in China: a single-center short-term observational cohort study. Bone marrow transplantation 59 (3) (2024)
Huangdu Hu, Yinping Wang, Jian Sun, Yuting Wang, Junxin Zhou, Qiucheng Shi, Xinhong Han, Yan Jiang, De-Pei Wu, Xiaojun Huang, Yunsong Yu
Risk factors and molecular epidemiology of intestinal colonization by carbapenem-resistant Gram-negative bacteria in patients with hematological diseases: a multicenter case‒control study. Microbiology spectrum 12 (7) (2024)
Zhibo Zhang, Jia Yin, Guoli Lian, Xiebing Bao, Meng Hu, Zhenfang Liu, Yuan Yu, Ruihua Mi, Yabei Zuo, Pengcheng Shi, Weiyan Zheng, Qian Jiang, Hongying Chao, Peifang Xiao, Weijuan Yu, Yanqiu Han, Yu Wu, Yan Zeng, De-Pei Wu, Xiaofei Yang, Su-Ning Chen
A multicenter retrospective comparison between systemic mastocytosis with t(8;21) AML and KIT mutant t(8;21) AML. Blood advances 8 (4) (2024)
Liangliang Wu, Limin Liu, Xin Zhao, Ming Zhou, Andie Fu, Yuping Zhang, Wenrui Yang, Xiaowei Chen, Wenjian Mo, Caixia Wang, Yumiao Li, Shilin Xu, Shiyi Pan, Ruiqing Zhou, Fankai Meng, Fengkui Zhang, De-Pei Wu, Shunqing Wang
Unrelated donor hematopoietic stem cell transplantation compared to immunosuppressive therapy plus eltrombopag as first-line treatment for adults with severe aplastic anemia. Blood cancer journal 14 (1) (2024)
Huangdu Hu, Yinping Wang, Jian Sun, Yuting Wang, Junxin Zhou, Qiucheng Shi, Xinhong Han, Yan Jiang, De-Pei Wu, Xiaojun Huang, Yunsong Yu
Risk factors and molecular epidemiology of intestinal colonization by carbapenem-resistant Gram-negative bacteria in patients with hematological diseases: a multicenter case‒control study. Microbiology spectrum (2024)
Jean El-Cheikh, Maud Ngoya, Jacques-Emmanuel Galimard, Péter Reményi, Alexander Dmitrievich Kulagin, Mahmoud Aljurf, Ashrafsadat Mousavi, De-Pei Wu, Tulay Ozcelik, Urpu Salmenniemi, Cristina Castilla-Llorente, Gerard Sociè, Grzegorz Helbig, Thomas Schroeder, Ioanna Sakellari, Alessandro Rambaldi, Richard Burt, Alessandro Busca, Marie Balsat, Matthias Stelljes, Eolia Brissot, Sebastien Giebel, Zinaida Perić, Arnon Nagler, Ali Bazarbachi, Fabio Ciceri, Florent Malard
Prognostic factors impacting post-transplant outcomes in adult T-cell acute lymphoblastic leukemia: a registry-based study by the EBMT acute leukemia working party. Bone marrow transplantation (2024)
Zhiyu Zhang, Man Qiao, Xiebing Bao, Jing Lu, Jingren Zhang, Xueqing Dou, Xuefeng He, Xiao-Jin Wu, Chengcheng Fu, Xiao-Wen Tang, Miao Miao, Yue Han, Sheng-Li Xue, Huiying Qiu, Caixia Li, Ying Wang, Zhengming Jin, De-Pei Wu, Su-Ning Chen
Influence of the Omicron outbreak on allo-HSCT recipients in China: a single-center short-term observational cohort study. Bone marrow transplantation (2024)
Huangdu Hu, Yinping Wang, Jian Sun, Yuting Wang, Junxin Zhou, Qiucheng Shi, Xinhong Han, Yan Jiang, De-Pei Wu, Xiaojun Huang, Yunsong Yu
Risk factors and molecular epidemiology of intestinal colonization by carbapenem-resistant Gram-negative bacteria in patients with hematological diseases: a multicenter case‒control study. Microbiology spectrum 12 (7) (2024)
Hong Wang, Xueqian Li, Jiaqian Qi, Hong Liu, Tiantian Chu, Xiaoyan Xu, Huiying Qiu, Chengcheng Fu, Xiaowen Tang, Changgeng Ruan, De-Pei Wu, Yue Han
Prognostic mutations identified by whole-exome sequencing and validation of the Molecular International Prognostic Scoring System in myelodysplastic syndromes after allogeneic haematopoietic stem cell transplantation. British journal of haematology (2024)
Yifan Shen, Minyuan Liu, Danya Shen, Mengqian Chu, Xuekai Li, Xiang Zhang, Yi Fan, Jia Chen, De-Pei Wu, Shaoyan Hu, Yang Xu
Busulfan plus cyclophosphamide vs. total body irradiation plus cyclophosphamide for allogeneic hematopoietic stem cell transplantation in patients with acute T lymphoblastic leukemia: a large-scale propensity score matching-based study. Bone marrow transplantation 59 (7) (2024)
Jean El-Cheikh, Maud Ngoya, Jacques-Emmanuel Galimard, Péter Reményi, Alexander Dmitrievich Kulagin, Mahmoud Aljurf, Ashrafsadat Mousavi, De-Pei Wu, Tulay Ozcelik, Urpu Salmenniemi, Cristina Castilla-Llorente, Gerard Sociè, Grzegorz Helbig, Thomas Schroeder, Ioanna Sakellari, Alessandro Rambaldi, Richard Burt, Alessandro Busca, Marie Balsat, Matthias Stelljes, Eolia Brissot, Sebastien Giebel, Zinaida Perić, Arnon Nagler, Ali Bazarbachi, Fabio Ciceri, Florent Malard
Prognostic factors impacting post-transplant outcomes in adult T-cell acute lymphoblastic leukemia: a registry-based study by the EBMT acute leukemia working party. Bone marrow transplantation 59 (9) (2024)
Jinjin Zhu, Mimi Xu, Yi-Shan Ye, Yuhua Ru, Yiyang Ding, Xiaoli Li, Huanle Gong, Biqi Zhou, Yi Fan, Yuqing Tu, Yang Xu, He Huang, Jia Chen, De-Pei Wu
Haploidentical-cord blood stem cell transplantation versus haploidentical stem cell transplantation for non-CR acute leukemia patients: a multicenter study. Bone marrow transplantation (2024)
Zhibo Zhang, Jia Yin, Guoli Lian, Xiebing Bao, Meng Hu, Zhenfang Liu, Yuan Yu, Ruihua Mi, Yabei Zuo, Pengcheng Shi, Weiyan Zheng, Qian Jiang, Hongying Chao, Peifang Xiao, Weijuan Yu, Yanqiu Han, Yu Wu, Yan Zeng, De-Pei Wu, Xiaofei Yang, Su-Ning Chen
A multicenter retrospective comparison between systemic mastocytosis with t(8;21) AML and KIT mutant t(8;21) AML. Blood advances 8 (4) (2024)
Rama Al Hamed, Myriam Labopin, De-Pei Wu, Tobias Gedde-Dahl, Mahmoud Aljurf, Edouard Forcade, Urpu Salmenniemi, Jakob R Passweg, Johan Maertens, Thomas Pabst, Jurjen Versluis, Maija Itäla-Remes, Xiao-Jun Huang, Gwendolyn Van Gorkom, Thomas Schroeder, Jaime Sanz Caballer, Didier Blaise, Péter Reményi, Urs Schanz, Aleksandra Holowiecka, Norbert-Claude Gorin, Fabio Ciceri, Florent Malard
Allogeneic stem cell transplantation in de novo core-binding factor acute myeloid leukemia in first complete remission: data from the EBMT. Bone marrow transplantation (2024)
Yue Song, Fei Zhou, Feng Du, Ziyan Wang, Liyun Bai, Yifang Yao, Limin Liu, Xiao Ma, Suning Chen, De-Pei Wu, Xuefeng He
Combined emapalumab and ruxolitinib in patients with haemophagocytic Lymphohistiocytosis. Blood cancer journal 14 (1) (2024)
Yue Song, Fei Zhou, Feng Du, Ziyan Wang, Liyun Bai, Yifang Yao, Limin Liu, Xiao Ma, Suning Chen, De-Pei Wu, Xuefeng He
Combined emapalumab and ruxolitinib in patients with haemophagocytic Lymphohistiocytosis. Blood cancer journal 14 (1) (2024)
Zhiyu Zhang, Man Qiao, Xiebing Bao, Jing Lu, Jingren Zhang, Xueqing Dou, Xuefeng He, Xiao-Jin Wu, Chengcheng Fu, Xiao-Wen Tang, Miao Miao, Yue Han, Sheng-Li Xue, Huiying Qiu, Caixia Li, Ying Wang, Zhengming Jin, De-Pei Wu, Su-Ning Chen
Influence of the Omicron outbreak on allo-HSCT recipients in China: a single-center short-term observational cohort study. Bone marrow transplantation 59 (3) (2024)
Yujie Liu, Yuqing Tu, Jinyan Xiao, Yifan Shen, Biqi Zhou, Qiannan Yang, Lei Yu, Lijuan Qi, Jia Chen, Tianhui Liu, De-Pei Wu, Yang Xu
Clinical outcomes of patients with lymphoid blastic phase of chronic myeloid leukemia treated with CAR T-cell therapy. Blood cancer journal 14 (1) (2024)
Yi-Shan Ye, Myriam Labopin, Jia Chen, De-Pei Wu, Tobias Gedde-Dahl, Didier Blaise, Gerard Sociè, Edouard Forcade, Urpu Salmenniemi, Sébastien Maury, Jurjen Versluis, Ali Bazarbachi, Arnon Nagler, Eolia Brissot, Lin Li, Yi Luo, Jimin Shi, Fabio Ciceri, He Huang, Florent Malard, Norbert-Claude Gorin
Lower relapse incidence with HAPLO versus MSD or MUD HCTs for AML patients with KMT2A rearrangement: a study from the Global Committee and the ALWP of the EBMT. Blood cancer journal 14 (1) (2024)
Si-Ning Liu, Xin-Yue Zhang, Haiping Dai, Wei Cui, Jia Yin, Zheng Li, Xiao Yang, Chunxiu Yang, Sheng-Li Xue, Huiying Qiu, Miao Miao, Suning Chen, Zhengming Jin, Chengcheng Fu, Caixia Li, Aining Sun, Yue Han, Ying Wang, Lei Yu, De-Pei Wu, Qingya Cui, Xiao-Wen Tang
Which one is better for refractory/relapsed acute B-cell lymphoblastic leukemia: Single-target (CD19) or dual-target (tandem or sequential CD19/CD22) CAR T-cell therapy? Blood cancer journal 13 (1) (2023)
Zhiyou Yu, Yao Yao, Yanming Zhang, Jia Chen, Yang Xu, Shengli Xue, Huiying Qiu, Xiaowen Tang, Yue Han, Suning Chen, Aining Sun, De-Pei Wu, Ying Wang
Outcomes of adult patients with type 1 primary refractory acute myeloid leukemia: a single center experience. Hematology (Amsterdam, Netherlands) 28 (1) (2023)
Yan Qiu, Chao-Ling Wan, Ming-Zhu Xu, Hai-Xia Zhou, Mei-Jing Liu, Wen-Jie Gong, Li-Qing Kang, Ai-Ning Sun, Lei Yu, De-Pei Wu, Chong-Sheng Qian, Sheng-Li Xue
Safety and efficacy of CD22 and CD19 CAR-T bridging auto-HSCT as consolidation therapy for AYA and adult B-ALL. Blood cancer journal 13 (1) (2023)
Yan Qiu, Chao-Ling Wan, Ming-Zhu Xu, Hai-Xia Zhou, Mei-Jing Liu, Wen-Jie Gong, Li-Qing Kang, Ai-Ning Sun, Lei Yu, De-Pei Wu, Chong-Sheng Qian, Sheng-Li Xue
Safety and efficacy of CD22 and CD19 CAR-T bridging auto-HSCT as consolidation therapy for AYA and adult B-ALL. Blood cancer journal 13 (1) (2023)
Zhenzhen Yao, Bin Gu, Jia Chen, Yang Xu, Feng Chen, Sheng-Li Xue, Huiying Qiu, Xiao-Wen Tang, Yue Han, Suning Chen, Aining Sun, Lei Yu, Yanming Zhang, De-Pei Wu, Ying Wang
CD19 chimeric antigen receptor T-cell therapy in adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia without complete molecular response at 3 months. Blood cancer journal 13 (1) (2023)
Jundan Xie, Xiebing Bao, Sheng-Li Xue, Hongjie Shen, Jiannong Cen, Li Yao, Jinlan Pan, MIngqing Zhu, Dandan Liu, Xiaohui Hu, Qian Wu, Jingren Zhang, Haiping Dai, Yanglin Cao, Xuefeng He, Xiaowen Tang, Ai-Ning Sun, Ying Wang, Jianhong Fu, Huiying Qiu, Xiaofei Yang, Su-Ning Chen, De-Pei Wu
Venetoclax with Decitabine as Frontline Treatment for Younger Adults with Newly Diagnosed ELN Adverse-Risk AML. Blood (2023)
Si-Ning Liu, Xin-Yue Zhang, Haiping Dai, Wei Cui, Jia Yin, Zheng Li, Xiao Yang, Chunxiu Yang, Sheng-Li Xue, Huiying Qiu, Miao Miao, Suning Chen, Zhengming Jin, Chengcheng Fu, Caixia Li, Aining Sun, Yue Han, Ying Wang, Lei Yu, De-Pei Wu, Qingya Cui, Xiao-Wen Tang
Which one is better for refractory/relapsed acute B-cell lymphoblastic leukemia: Single-target (CD19) or dual-target (tandem or sequential CD19/CD22) CAR T-cell therapy? Blood cancer journal 13 (1) (2023)
Yan Qiu, Chao-Ling Wan, Ming-Zhu Xu, Hai-Xia Zhou, Mei-Jing Liu, Wen-Jie Gong, Li-Qing Kang, Ai-Ning Sun, Lei Yu, De-Pei Wu, Chong-Sheng Qian, Sheng-Li Xue
Safety and efficacy of CD22 and CD19 CAR-T bridging auto-HSCT as consolidation therapy for AYA and adult B-ALL. Blood cancer journal 13 (1) (2023)
Yan Qiu, Chao-Ling Wan, Ming-Zhu Xu, Hai-Xia Zhou, Mei-Jing Liu, Wen-Jie Gong, Li-Qing Kang, Ai-Ning Sun, Lei Yu, De-Pei Wu, Chong-Sheng Qian, Sheng-Li Xue
Safety and efficacy of CD22 and CD19 CAR-T bridging auto-HSCT as consolidation therapy for AYA and adult B-ALL. Blood cancer journal 13 (1) (2023)
Keyuan Zhang, Xiang Zhang, Yang Xu, Sheng-Li Xue, Huiying Qiu, Xiao-Wen Tang, Yue Han, Suning Chen, Aining Sun, Yanming Zhang, De-Pei Wu, Ying Wang
Efficacy of venetoclax combined with hypomethylating agents in young, and unfit patients with newly diagnosed core binding factor acute myeloid leukemia. Blood cancer journal 13 (1) (2023)
Si-Ning Liu, Xin-Yue Zhang, Haiping Dai, Wei Cui, Jia Yin, Zheng Li, Xiao Yang, Chunxiu Yang, Sheng-Li Xue, Huiying Qiu, Miao Miao, Suning Chen, Zhengming Jin, Chengcheng Fu, Caixia Li, Aining Sun, Yue Han, Ying Wang, Lei Yu, De-Pei Wu, Qingya Cui, Xiao-Wen Tang
Which one is better for refractory/relapsed acute B-cell lymphoblastic leukemia: Single-target (CD19) or dual-target (tandem or sequential CD19/CD22) CAR T-cell therapy? Blood cancer journal 13 (1) (2023)
Dongpeng Jiang, Haiwen Huang, Huimin Qin, Koukou Tang, Xiangru Shi, Tingting Zhu, Yuqing Gao, Ying Zhang, Xiaopeng Tian, Jianhong Fu, Weiwei Qu, Weilan Cai, Yang Xu, De-Pei Wu, Jianhong Chu
Chimeric antigen receptor T cells targeting FcRH5 provide robust tumour-specific responses in murine xenograft models of multiple myeloma. Nature communications 14 (1) (2023)
Si-Ning Liu, Xin-Yue Zhang, Haiping Dai, Wei Cui, Jia Yin, Zheng Li, Xiao Yang, Chunxiu Yang, Sheng-Li Xue, Huiying Qiu, Miao Miao, Suning Chen, Zhengming Jin, Chengcheng Fu, Caixia Li, Aining Sun, Yue Han, Ying Wang, Lei Yu, De-Pei Wu, Qingya Cui, Xiao-Wen Tang
Which one is better for refractory/relapsed acute B-cell lymphoblastic leukemia: Single-target (CD19) or dual-target (tandem or sequential CD19/CD22) CAR T-cell therapy? Blood cancer journal 13 (1) (2023)
Si-Ning Liu, Xin-Yue Zhang, Haiping Dai, Wei Cui, Jia Yin, Zheng Li, Xiao Yang, Chunxiu Yang, Sheng-Li Xue, Huiying Qiu, Miao Miao, Suning Chen, Zhengming Jin, Chengcheng Fu, Caixia Li, Aining Sun, Yue Han, Ying Wang, Lei Yu, De-Pei Wu, Qingya Cui, Xiao-Wen Tang
Which one is better for refractory/relapsed acute B-cell lymphoblastic leukemia: Single-target (CD19) or dual-target (tandem or sequential CD19/CD22) CAR T-cell therapy? Blood cancer journal 13 (1) (2023)
Li Huo, Zhibo Zhang, Haixia Zhou, Jundan Xie, Airui Jiang, Qian Wang, Zixuan Ding, Hai-Ping Dai, Dandan Liu, Ni Wu, Qiaocheng Qiu, Liang Ma, Man Wang, Wenjuan Wang, Sheng-Li Xue, Zixing Chen, De-Pei Wu, Hong Yao, Suning Chen, Hongjie Shen
Causative germline variant p.Y259C of DDX41 recurrently identified in acute lymphoblastic leukaemia. British journal of haematology (2023)
Zhenzhen Yao, Bin Gu, Jia Chen, Yang Xu, Feng Chen, Sheng-Li Xue, Huiying Qiu, Xiao-Wen Tang, Yue Han, Suning Chen, Aining Sun, Lei Yu, Yanming Zhang, De-Pei Wu, Ying Wang
CD19 chimeric antigen receptor T-cell therapy in adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia without complete molecular response at 3 months. Blood cancer journal 13 (1) (2023)
Shiyuan Zhou, Yingying Zhai, Lingzhi Yan, Xiaolan Shi, Jingjing Shang, De-Pei Wu, Chengcheng Fu, Song Jin
Busulfan/Cyclophosphamide Compared with Melphalan as a Conditioning Regimen for Autologous Transplantation of Multiple Myeloma: A Long-Term Assessment. Journal of clinical medicine 12 (19) (2023)
Si-Ning Liu, Xin-Yue Zhang, Haiping Dai, Wei Cui, Jia Yin, Zheng Li, Xiao Yang, Chunxiu Yang, Sheng-Li Xue, Huiying Qiu, Miao Miao, Suning Chen, Zhengming Jin, Chengcheng Fu, Caixia Li, Aining Sun, Yue Han, Ying Wang, Lei Yu, De-Pei Wu, Qingya Cui, Xiao-Wen Tang
Which one is better for refractory/relapsed acute B-cell lymphoblastic leukemia: Single-target (CD19) or dual-target (tandem or sequential CD19/CD22) CAR T-cell therapy? Blood cancer journal 13 (1) (2023)
Zhenzhen Yao, Bin Gu, Jia Chen, Yang Xu, Feng Chen, Sheng-Li Xue, Huiying Qiu, Xiao-Wen Tang, Yue Han, Suning Chen, Aining Sun, Lei Yu, Yanming Zhang, De-Pei Wu, Ying Wang
CD19 chimeric antigen receptor T-cell therapy in adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia without complete molecular response at 3 months. Blood cancer journal 13 (1) (2023)
Qiao Cheng, Dong Wang, Xiaoxuan Lai, Yin Liu, Yibo Zuo, Wenli Zhang, Lei Lei, Jia Chen, Hong Liu, Ying Wang, Haiyan Liu, Hui Zheng, De-Pei Wu, Yang Xu
The OTUD1-Notch2-ICD axis orchestrates allogeneic T cell-mediated graft-versus-host disease. Blood (2022)
Limin Liu, Shunqing Wang, Erlie Jiang, Yanming Zhang, Jianyong Li, Yuewen Fu, Meiqing Lei, Kailin Xu, Mingzhen Yang, Yinghao Lu, Miao Miao, De-Pei Wu
Haploidentical vs matched sibling donor transplant for paroxysmal nocturnal haemoglobinuria: A multicenter study. Blood cancer journal 12 (6) (2022)
Zhenzhen Yao, Bin Gu, Yanming Zhang, Jiaqian Qi, Jia Chen, Yang Xu, Feng Chen, Xiao Ma, Miao Miao, Sheng-Li Xue, Huiying Qiu, Xiao-Wen Tang, Yue Han, Suning Chen, Aining Sun, Lei Yu, De-Pei Wu, Ying Wang
CD19 chimeric antigen receptor T-cell therapy as a bridge therapy for allogeneic hematopoietic stem cell transplantation in patients with relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia. Bone marrow transplantation (2022)
Qiao Cheng, Dong Wang, Xiaoxuan Lai, Yin Liu, Yibo Zuo, Wenli Zhang, Lei Lei, Jia Chen, Hong Liu, Ying Wang, Haiyan Liu, Hui Zheng, De-Pei Wu, Yang Xu
The OTUD1-Notch2-ICD axis orchestrates allogeneic T cell-mediated graft-versus-host disease. Blood (2022)
Jing Deng, Aneel Paulus, Douglas D Fang, Alak Manna, Guangfeng Wang, Hengbang Wang, Saijie Zhu, Jianyong Chen, Ping Min, Yan Yin, Navnita Dutta, Nabanita Halder, Gina Ciccio, John A Copland Iii, James L Miller, Bing Han, Longchuan Bai, Liu Liu, Mi Wang, Donna McEachern, Sally Przybranowski, Chao-Yie Yang, Jeanne A Stuckey, De-Pei Wu, Caixia Li, Jeremy Adam Ryan, Anthony G Letai, Sikandar Ailawadhi, Dajun Yang, Shaomeng Wang, Asher A Chanan-Khan, Yifan Zhai
Lisaftoclax (APG-2575) is a Novel BCL-2 Inhibitor with Robust Antitumor Activity in Preclinical Models of Hematologic Malignancy. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Huanle Gong, Shoubao Ma, Jia Chen, Bingyu Yang, Shuangzhu Liu, Xin Liu, Jingjing Han, Xiao-Jin Wu, Lei Lei, Zhinan Yin, Hongjian Sun, Di Yu, Haiyan Liu, Yang Xu, De-Pei Wu
Dendritic cell-derived IL-27 p28 regulates T cell program in pathogenicity and alleviates acute graft-versus-host disease. Signal transduction and targeted therapy 7 (1) (2022)